Burkina Faso is among ten countries most affected by malaria. The global community still struggles to eliminate this debilitating disease that is a leading cause of mortality in children younger than 5 years.1 Public health efforts include treatment, c...
Repeated high-dose ivermectin MDA integrated with SMC distributions at the study site did not reduce malaria incidence among children relative to placebo MDA, despite evidence that, compared with the control group, mosquito survivorship in the first ye...
In response to the ongoing evolution of SARS-CoV-2, vaccine manufacturers have released updated COVID-19 vaccines annually since 2022. For much of 2024, the global spread was dominated by the JN.1 lineage of viruses,1 which are antigenically quite dist...
The rapid spread and emergence of immune-evasive SARS-CoV-2 variants has led to a 2024 update of the COVID-19 vaccine. These variants include BA.2.86-lineage variants comprising more than 30 mutations within the spike that are different from XBB-lineag...
From the onset of the COVID-19 pandemic, a key question about SARS-CoV-2 permeated the global conversation: how does SARS-CoV-2 compare to seasonal influenza? The intense interest in comparing these two viruses (eg, in transmission dynamics, infectivit...
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections in infants younger than 6 months, resulting in an estimated 1·4 million hospital admissions each year worldwide.1 A maternal bivalent RSV prefusion F pro...
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections in infants younger than 6 months, resulting in an estimated 1·4 million hospital admissions each year worldwide.1 A maternal bivalent RSV prefusion F pro...
COVID-19 represented a greater disease burden than influenza, with more hospital admissions and deaths, and more severe disease (primarily among non-vaccinated people, those with comorbidities, and male patients). These results highlight the continued ...
COVID-19 represented a greater disease burden than influenza, with more hospital admissions and deaths, and more severe disease (primarily among non-vaccinated people, those with comorbidities, and male patients). These results highlight the continued ...
From the onset of the COVID-19 pandemic, a key question about SARS-CoV-2 permeated the global conversation: how does SARS-CoV-2 compare to seasonal influenza? The intense interest in comparing these two viruses (eg, in transmission dynamics, infectivit...
Colavita F, Carletti F, D'Abramo A, Nicastri E, Maggi F. Prolonged detection of Oropouche virus RNA in whole blood samples. Lancet Infect Dis 2025; 25: e11–12—In this Correspondence, the affiliation for all authors should have read “National Institute ...
Recently, XEC and KP.3.1.1 have surpassed KP.3 to become the globally dominant lineages of SARS-CoV-2 due to the unique N-terminal domain (NTD) mutations, including Ser31del in KP.3.1.1 and Thr22Asn and Phe59Ser in XEC.1–7 However, several sublineages ...
Over the past three decades, sexual health has become a major concern for global development projects. Governments, international organisations, and development agencies have mobilised and increased their investment in sexual and reproductive health pr...
Over the past three decades, sexual health has become a major concern for global development projects. Governments, international organisations, and development agencies have mobilised and increased their investment in sexual and reproductive health pr...
Through assessing the response and effect of three different epidemics across the continent of Africa (COVID-19, Ebola, and HIV), the book Human security and epidemics in Africa: learning from COVID-19, Ebola and HIV, edited by Caroline Varin and Andre...
Through assessing the response and effect of three different epidemics across the continent of Africa (COVID-19, Ebola, and HIV), the book Human security and epidemics in Africa: learning from COVID-19, Ebola and HIV, edited by Caroline Varin and Andre...